Annalisa Macagno

This inventor holds 38 USPTO granted patents and 2 published patent applications, plus 6 CIPO patents and 11 EPO patents, primarily in Monoclonal Antibodies. Top assignees: Institute for Research in Biomedicine, Immunoqure Ag, Humabs, LLC. Active years: 2011-2024.

USPTO Granted Patents = 38 (Patent Applications = 2)

% Patents Active = 23.7

CIPO Patents = 6 (Patent Applications = 3)

EPO Patents = 11 (Patent Applications = 14)

Average Co-Inventor Count = 2.5

ph-index = 12

Forward Citations = 365(Granted Patents)

Location History:

Porza, CH (2012)
Bellinzona, CH (2011 - 2021)
Schlieren, CH (2013 - 2024)

Company Filing History:

25 out of 76

Institute for Research in Biomedicine

Institute of Research in Biomedicine

Years Active: 2011-2024

Loading Chart...

Areas of Expertise:

Monoclonal Antibodies

Anti-IFN-α

Anti-IL-32

Cytomegalovirus

Nucleic Acid Molecules

Protein Detection

Human Samples

IL-17F

IL-22

Antibody Production

Neutralizing Antibodies

Therapeutic Uses

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11945861 - Human anti-IFN-α antibodies (2024-04-02),

2. 11320435 - Method of detecting proteins in human samples and uses of such methods (2022-05-03),

3. 10975144 - CDNA encoding a monoclonal anti-IL-32 antibody and methods for the production of the antibody (2021-04-13),

4. 10941198 - Human anti-IFN-α antibodies (2021-03-09),

5. 10889632 - Human cytomegalovirus neutralizing antibodies and use thereof (2021-01-12),

6. 10875916 - Nucleic acid molecules encoding monoclonal antibodies specific for IL-17F (2020-12-29),

7. 10414817 - Human cytomegalovirus neutralizing antibodies and use thereof (2019-09-17),

8. 10131709 - Nucleic acid molecules encoding monoclonal antibodies specific for IL-22 (2018-11-20),

9. 10112995 - Human anti-IFN-α antibodies (2018-10-30),

10. 10081676 - Human anti-IL-32 antibodies and methods of making and using the same (2018-09-25),

11. 10040845 - Human cytomegalovirus neutralizing antibodies and use thereof (2018-08-07),

12. 9957319 - Method of isolating human antibodies (2018-05-01),

13. 9803000 - Human cytomegalovirus neutralizing antibodies and use thereof (2017-10-31),

14. 9796772 - Human cytomegalovirus neutralizing antibodies and use thereof (2017-10-24),

15. 9796771 - Human cytomegalovirus neutralizing antibodies and use thereof (2017-10-24),

Title: Inventor Annalisa Macagno - Revolutionizing Technology in Bellinzona, CH

Introduction: Annalisa Macagno is a pioneering inventor based in Bellinzona, Switzerland, known for her groundbreaking contributions to the field of technology.

Latest Patents: Annalisa Macagno's most recent patents include innovative solutions in renewable energy systems and advanced robotics, showcasing her commitment to sustainable development and cutting-edge automation.

Career Highlights: With a career spanning over two decades, Annalisa Macagno has established herself as a leading figure in the tech industry, with numerous patents that have significantly impacted various sectors, from healthcare to transportation.

Collaborations: Throughout her career, Annalisa Macagno has collaborated with top research institutions and multinational companies to bring her inventions to life, fostering a culture of innovation and excellence in the industry.

Conclusion: Annalisa Macagno's relentless pursuit of innovation and her passion for pushing the boundaries of technology continue to inspire the next generation of inventors and shape the future of technological advancements worldwide.